This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Vanzago, IT (2014 - 2017)
- Vanzago Milan, IT (2024)
Company Filing History:
Years Active: 2014-2026
Title: The Innovative Contributions of Teresa Disingrini
Introduction
Teresa Disingrini is a prominent inventor based in Vanzago, Italy. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific diseases. With a total of six patents to her name, her work has the potential to impact the treatment of various health conditions.
Latest Patents
Among her latest patents is the invention of heterocondensed pyridone compounds and their use as IDH inhibitors. This invention relates to certain substituted heterocondensed pyridone analogues that modulate the activity of Isocitrate Dehydrogenase (IDH). The compounds are particularly useful in treating diseases caused by mutated IDH1 and/or mutated IDH2 enzymes, as well as IDH1 wild type enzymes, with a focus on cancer and immune-related disorders. Additionally, she has developed tricyclopyrazole derivatives, which are useful in treating diseases associated with altered protein kinase activity, including cancer and viral infections. These compounds also have applications in preventing AIDS development in HIV-infected individuals.
Career Highlights
Teresa Disingrini is currently employed at Nerviano Medical Sciences S.r.l., where she continues to innovate and contribute to the field of medicinal chemistry. Her work is characterized by a strong focus on developing novel therapeutic agents that address critical health challenges.
Collaborations
Throughout her career, Teresa has collaborated with notable colleagues, including Francesco Casuscelli and Sergio Mantegani. These collaborations have further enhanced her research and development efforts, leading to impactful innovations in the pharmaceutical industry.
Conclusion
Teresa Disingrini's contributions to the field of pharmaceutical sciences through her innovative patents demonstrate her commitment to advancing medical treatments. Her work not only showcases her expertise but also highlights the importance of collaboration in driving scientific progress.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile